APO Research
Talk to an analyst

APO RESEARCH · REPORT

Prostate Cancer Devices

Prostate cancer is cancer that starts in the prostate gland, a walnut sized gland at the base of the bladder in men. The treatment options for men with prostate cancer might include: surgery, brachytherapy, radiotherapy, hormonotherapy, chemotherapy, high intensity focused ultrasound (HIFU) and cryotherapy. In this report, the research team studied the robotic surgery, high intensity focused ultrasound (HIFU), cryotherapy, brachytherapy, and external beam radiation.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Prostate cancer is cancer that starts in the prostate gland, a walnut sized gland at the base of the bladder in men. The treatment options for men with prostate cancer might include: surgery, brachytherapy, radiotherapy, hormonotherapy, chemotherapy, high intensity focused ultrasound (HIFU) and cryotherapy. In this report, the research team studied the robotic surgery, high intensity focused ultrasound (HIFU), cryotherapy, brachytherapy, and external beam radiation.

Selected research

Market Outlook & Growth Opportunities

Global Prostate Cancer Devices Market Outlook and Growth Opportunities 2026

9 January 2026194 pages

Choose your research edition.

Industry ResearchProstate Cancer Devices Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Prostate Cancer Devices Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Prostate Cancer Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prostate Cancer Devices Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Prostate Cancer Devices Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Prostate cancer is cancer that starts in the prostate gland, a walnut sized gland at the base of the bladder in men. The treatment options for men with prostate cancer might include: surgery, brachytherapy, radiotherapy, hormonotherapy, chemotherapy, high intensity focused ultrasound (HIFU) and cryotherapy. In this report, the research team studied the robotic surgery, high intensity focused ultrasound (HIFU), cryotherapy, brachytherapy, and external beam radiation.

North America is the largest Prostate Cancer Devices market with about 49% market share. Europe is follower, accounting for about 27% market share.

The key players are Intuitive Surgical, Varian Medical Systems, Elekta, Accuray, Bard Medical (BD), Eckert & Ziegler, Healthtronics, EDAP TMS, SonaCare Medical, Galil Medical (BTG) etc. Top 5 companies occupied about 91% market share.

Read the full market overview

This report provides an overview of the global Prostate Cancer Devices market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Prostate Cancer Devices and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Prostate Cancer Devices revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Prostate Cancer Devices market.

Prostate Cancer Devices Segment by Company

Intuitive Surgical

Varian Medical Systems

Elekta

Accuray

Bard Medical (BD)

Eckert & Ziegler

Healthtronics

EDAP TMS

SonaCare Medical

Galil Medical (BTG)

Prostate Cancer Devices Segment by Type

Robotic Surgery Devices

EBRT Devices

Brachytherapy

HIFU Devices

Cryotherapy Devices

Prostate Cancer Devices Segment by Application

Hospitals

Ambulatory Surgical Centers

Prostate Cancer Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Prostate Cancer Devices status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Prostate Cancer Devices key companies, revenue, market share, and recent developments.

3. To split the Prostate Cancer Devices breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Prostate Cancer Devices market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Prostate Cancer Devices significant trends, drivers, influence factors in global and regions.

6. To analyze Prostate Cancer Devices competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prostate Cancer Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prostate Cancer Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prostate Cancer Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Prostate Cancer Devices industry.

Chapter 3: Detailed analysis of Prostate Cancer Devices company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Prostate Cancer Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Prostate Cancer Devices in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Prostate Cancer Devices Industry Trends Table 2. Prostate Cancer Devices Industry Drivers Table 3. Prostate Cancer Devices Industry Opportunities and Challenges Table 4. Prostate Cancer Devices Industry Restraints Table 5. Global Prostate Cancer Devices Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Prostate Cancer Devices Revenue Share by Company (2021-2026) Table 7. Global Prostate Cancer Devices Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Prostate Cancer Devices Key Company Manufacturing Base & Headquarters Table 9. Global Prostate Cancer Devices Company, Product Type & Application Table 10. Global Prostate Cancer Devices Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Prostate Cancer Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Robotic Surgery Devices Table 15. Significant Companies of EBRT Devices Table 16. Significant Companies of Brachytherapy Table 17. Significant Companies of HIFU Devices Table 18. Significant Companies of Cryotherapy Devices Table 19. Global Prostate Cancer Devices Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Prostate Cancer Devices Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global Prostate Cancer Devices Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global Prostate Cancer Devices Sales Value Share by Type (2021-2026) Table 23. Global Prostate Cancer Devices Sales Value Share by Type (2027-2032) Table 24. Significant Companies of Hospitals Table 25. Significant Companies of Ambulatory Surgical Centers Table 26. Global Prostate Cancer Devices Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Prostate Cancer Devices Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Prostate Cancer Devices Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Prostate Cancer Devices Sales Value Share by Application (2021-2026) Table 30. Global Prostate Cancer Devices Sales Value Share by Application (2027-2032) Table 31. Global Prostate Cancer Devices Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Prostate Cancer Devices Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Prostate Cancer Devices Sales Value Share by Region (2021-2026) Table 34. Global Prostate Cancer Devices Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Prostate Cancer Devices Sales Value Share by Region (2027-2032) Table 36. Global Prostate Cancer Devices Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Prostate Cancer Devices Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Prostate Cancer Devices Sales Value Market Share by Country (2021-2026) Table 39. Global Prostate Cancer Devices Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Prostate Cancer Devices Sales Value Market Share by Country (2027-2032) Table 41. Intuitive Surgical Company Information Table 42. Intuitive Surgical Business Overview Table 43. Intuitive Surgical Prostate Cancer Devices Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Intuitive Surgical Prostate Cancer Devices Product Portfolio Table 45. Intuitive Surgical Recent Development Table 46. Varian Medical Systems Company Information Table 47. Varian Medical Systems Business Overview Table 48. Varian Medical Systems Prostate Cancer Devices Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Varian Medical Systems Prostate Cancer Devices Product Portfolio Table 50. Varian Medical Systems Recent Development Table 51. Elekta Company Information Table 52. Elekta Business Overview Table 53. Elekta Prostate Cancer Devices Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Elekta Prostate Cancer Devices Product Portfolio Table 55. Elekta Recent Development Table 56. Accuray Company Information Table 57. Accuray Business Overview Table 58. Accuray Prostate Cancer Devices Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Accuray Prostate Cancer Devices Product Portfolio Table 60. Accuray Recent Development Table 61. Bard Medical (BD) Company Information Table 62. Bard Medical (BD) Business Overview Table 63. Bard Medical (BD) Prostate Cancer Devices Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Bard Medical (BD) Prostate Cancer Devices Product Portfolio Table 65. Bard Medical (BD) Recent Development Table 66. Eckert & Ziegler Company Information Table 67. Eckert & Ziegler Business Overview Table 68. Eckert & Ziegler Prostate Cancer Devices Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Eckert & Ziegler Prostate Cancer Devices Product Portfolio Table 70. Eckert & Ziegler Recent Development Table 71. Healthtronics Company Information Table 72. Healthtronics Business Overview Table 73. Healthtronics Prostate Cancer Devices Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Healthtronics Prostate Cancer Devices Product Portfolio Table 75. Healthtronics Recent Development Table 76. EDAP TMS Company Information Table 77. EDAP TMS Business Overview Table 78. EDAP TMS Prostate Cancer Devices Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. EDAP TMS Prostate Cancer Devices Product Portfolio Table 80. EDAP TMS Recent Development Table 81. SonaCare Medical Company Information Table 82. SonaCare Medical Business Overview Table 83. SonaCare Medical Prostate Cancer Devices Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. SonaCare Medical Prostate Cancer Devices Product Portfolio Table 85. SonaCare Medical Recent Development Table 86. Galil Medical (BTG) Company Information Table 87. Galil Medical (BTG) Business Overview Table 88. Galil Medical (BTG) Prostate Cancer Devices Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Galil Medical (BTG) Prostate Cancer Devices Product Portfolio Table 90. Galil Medical (BTG) Recent Development Table 91. Research Programs/Design for This Report Table 92. Authors List of This Report Table 93. Secondary Sources Table 94. Primary Sources List of Figures Figure 1. Prostate Cancer Devices Product Image Figure 2. Global Prostate Cancer Devices Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prostate Cancer Devices Market Size (2021-2032) & (US$ Million) Figure 4. Global Prostate Cancer Devices Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Robotic Surgery Devices Image Figure 8. EBRT Devices Image Figure 9. Brachytherapy Image Figure 10. HIFU Devices Image Figure 11. Cryotherapy Devices Image Figure 12. Global Prostate Cancer Devices Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global Prostate Cancer Devices Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global Prostate Cancer Devices Sales Value Share by Type (2021-2032) Figure 15. Hospitals Image Figure 16. Ambulatory Surgical Centers Image Figure 17. Global Prostate Cancer Devices Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Prostate Cancer Devices Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Prostate Cancer Devices Sales Value Share by Application (2021-2032) Figure 20. Global Prostate Cancer Devices Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Prostate Cancer Devices Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Prostate Cancer Devices Sales Value (2021-2032) & (US$ Million) Figure 23. North America Prostate Cancer Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Prostate Cancer Devices Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Prostate Cancer Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Prostate Cancer Devices Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Prostate Cancer Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Prostate Cancer Devices Sales Value (2021-2032) & (US$ Million) Figure 29. South America Prostate Cancer Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Prostate Cancer Devices Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Prostate Cancer Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Prostate Cancer Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Prostate Cancer Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Prostate Cancer Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Prostate Cancer Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Prostate Cancer Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Prostate Cancer Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Prostate Cancer Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Prostate Cancer Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Prostate Cancer Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Prostate Cancer Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Prostate Cancer Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Prostate Cancer Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Prostate Cancer Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Prostate Cancer Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Prostate Cancer Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Prostate Cancer Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Prostate Cancer Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Prostate Cancer Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Prostate Cancer Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Prostate Cancer Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Prostate Cancer Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Prostate Cancer Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Prostate Cancer Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Prostate Cancer Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Prostate Cancer Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Prostate Cancer Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Prostate Cancer Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Prostate Cancer Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Robotic Surgery Devices
  • EBRT Devices
  • Brachytherapy
  • HIFU Devices
  • Cryotherapy Devices
Applications
  • Hospitals
  • Ambulatory Surgical Centers
Companies covered
  • Intuitive Surgical
  • Varian Medical Systems
  • Elekta
  • Accuray
  • Bard Medical (BD)
  • Eckert & Ziegler
  • Healthtronics
  • EDAP TMS
  • SonaCare Medical
  • Galil Medical (BTG)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Prostate Cancer Devices Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Prostate Cancer Devices Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Prostate Cancer Devices Market Dynamics
  1. 2.1 Prostate Cancer Devices Industry Trends
  2. 2.2 Prostate Cancer Devices Industry Drivers
  3. 2.3 Prostate Cancer Devices Industry Opportunities and Challenges
  4. 2.4 Prostate Cancer Devices Industry Restraints
3 Prostate Cancer Devices Market by Company
  1. 3.1 Global Prostate Cancer Devices Company Revenue Ranking in 2025
  2. 3.2 Global Prostate Cancer Devices Revenue by Company (2021-2026)
  3. 3.3 Global Prostate Cancer Devices Company Ranking (2024-2026)
  4. 3.4 Global Prostate Cancer Devices Company Manufacturing Base and Headquarters
  5. 3.5 Global Prostate Cancer Devices Company Product Type and Application
  6. 3.6 Global Prostate Cancer Devices Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Prostate Cancer Devices Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Prostate Cancer Devices Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Prostate Cancer Devices Market by Type
  1. 4.1 Prostate Cancer Devices Type Introduction
  2. 4.1.1 Robotic Surgery Devices
  3. 4.1.2 EBRT Devices
  4. 4.1.3 Brachytherapy
  5. 4.1.4 HIFU Devices
  6. 4.1.5 Cryotherapy Devices
  7. 4.2 Global Prostate Cancer Devices Sales Value by Type
  8. 4.2.1 Global Prostate Cancer Devices Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Prostate Cancer Devices Sales Value by Type (2021-2032)
  10. 4.2.3 Global Prostate Cancer Devices Sales Value Share by Type (2021-2032)
5 Prostate Cancer Devices Market by Application
  1. 5.1 Prostate Cancer Devices Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Ambulatory Surgical Centers
  4. 5.2 Global Prostate Cancer Devices Sales Value by Application
  5. 5.2.1 Global Prostate Cancer Devices Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Prostate Cancer Devices Sales Value by Application (2021-2032)
  7. 5.2.3 Global Prostate Cancer Devices Sales Value Share by Application (2021-2032)
6 Prostate Cancer Devices Regional Value Analysis
  1. 6.1 Global Prostate Cancer Devices Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Prostate Cancer Devices Sales Value by Region (2021-2032)
  3. 6.2.1 Global Prostate Cancer Devices Sales Value by Region: 2021-2026
  4. 6.2.2 Global Prostate Cancer Devices Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Prostate Cancer Devices Sales Value (2021-2032)
  7. 6.3.2 North America Prostate Cancer Devices Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Prostate Cancer Devices Sales Value (2021-2032)
  10. 6.4.2 Europe Prostate Cancer Devices Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Prostate Cancer Devices Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Prostate Cancer Devices Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Prostate Cancer Devices Sales Value (2021-2032)
  16. 6.6.2 South America Prostate Cancer Devices Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Prostate Cancer Devices Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Prostate Cancer Devices Sales Value Share by Country, 2025 VS 2032
7 Prostate Cancer Devices Country-level Value Analysis
  1. 7.1 Global Prostate Cancer Devices Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Prostate Cancer Devices Sales Value by Country (2021-2032)
  3. 7.2.1 Global Prostate Cancer Devices Sales Value by Country (2021-2026)
  4. 7.2.2 Global Prostate Cancer Devices Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Prostate Cancer Devices Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Prostate Cancer Devices Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Prostate Cancer Devices Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Prostate Cancer Devices Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Prostate Cancer Devices Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Prostate Cancer Devices Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Prostate Cancer Devices Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Prostate Cancer Devices Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Prostate Cancer Devices Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Prostate Cancer Devices Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Prostate Cancer Devices Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Prostate Cancer Devices Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Prostate Cancer Devices Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Prostate Cancer Devices Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Prostate Cancer Devices Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Prostate Cancer Devices Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Prostate Cancer Devices Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Prostate Cancer Devices Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Prostate Cancer Devices Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Prostate Cancer Devices Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Prostate Cancer Devices Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Prostate Cancer Devices Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Prostate Cancer Devices Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Prostate Cancer Devices Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Prostate Cancer Devices Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Prostate Cancer Devices Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Prostate Cancer Devices Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Prostate Cancer Devices Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Prostate Cancer Devices Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Prostate Cancer Devices Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Intuitive Surgical
  2. 8.1.1 Intuitive Surgical Company Information
  3. 8.1.2 Intuitive Surgical Business Overview
  4. 8.1.3 Intuitive Surgical Prostate Cancer Devices Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Intuitive Surgical Prostate Cancer Devices Product Portfolio
  6. 8.1.5 Intuitive Surgical Recent Developments
  7. 8.2 Varian Medical Systems
  8. 8.2.1 Varian Medical Systems Company Information
  9. 8.2.2 Varian Medical Systems Business Overview
  10. 8.2.3 Varian Medical Systems Prostate Cancer Devices Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Varian Medical Systems Prostate Cancer Devices Product Portfolio
  12. 8.2.5 Varian Medical Systems Recent Developments
  13. 8.3 Elekta
  14. 8.3.1 Elekta Company Information
  15. 8.3.2 Elekta Business Overview
  16. 8.3.3 Elekta Prostate Cancer Devices Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Elekta Prostate Cancer Devices Product Portfolio
  18. 8.3.5 Elekta Recent Developments
  19. 8.4 Accuray
  20. 8.4.1 Accuray Company Information
  21. 8.4.2 Accuray Business Overview
  22. 8.4.3 Accuray Prostate Cancer Devices Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Accuray Prostate Cancer Devices Product Portfolio
  24. 8.4.5 Accuray Recent Developments
  25. 8.5 Bard Medical (BD)
  26. 8.5.1 Bard Medical (BD) Company Information
  27. 8.5.2 Bard Medical (BD) Business Overview
  28. 8.5.3 Bard Medical (BD) Prostate Cancer Devices Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Bard Medical (BD) Prostate Cancer Devices Product Portfolio
  30. 8.5.5 Bard Medical (BD) Recent Developments
  31. 8.6 Eckert & Ziegler
  32. 8.6.1 Eckert & Ziegler Company Information
  33. 8.6.2 Eckert & Ziegler Business Overview
  34. 8.6.3 Eckert & Ziegler Prostate Cancer Devices Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Eckert & Ziegler Prostate Cancer Devices Product Portfolio
  36. 8.6.5 Eckert & Ziegler Recent Developments
  37. 8.7 Healthtronics
  38. 8.7.1 Healthtronics Company Information
  39. 8.7.2 Healthtronics Business Overview
  40. 8.7.3 Healthtronics Prostate Cancer Devices Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Healthtronics Prostate Cancer Devices Product Portfolio
  42. 8.7.5 Healthtronics Recent Developments
  43. 8.8 EDAP TMS
  44. 8.8.1 EDAP TMS Company Information
  45. 8.8.2 EDAP TMS Business Overview
  46. 8.8.3 EDAP TMS Prostate Cancer Devices Revenue and Gross Margin (2021-2026)
  47. 8.8.4 EDAP TMS Prostate Cancer Devices Product Portfolio
  48. 8.8.5 EDAP TMS Recent Developments
  49. 8.9 SonaCare Medical
  50. 8.9.1 SonaCare Medical Company Information
  51. 8.9.2 SonaCare Medical Business Overview
  52. 8.9.3 SonaCare Medical Prostate Cancer Devices Revenue and Gross Margin (2021-2026)
  53. 8.9.4 SonaCare Medical Prostate Cancer Devices Product Portfolio
  54. 8.9.5 SonaCare Medical Recent Developments
  55. 8.10 Galil Medical (BTG)
  56. 8.10.1 Galil Medical (BTG) Company Information
  57. 8.10.2 Galil Medical (BTG) Business Overview
  58. 8.10.3 Galil Medical (BTG) Prostate Cancer Devices Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Galil Medical (BTG) Prostate Cancer Devices Product Portfolio
  60. 8.10.5 Galil Medical (BTG) Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst